Tighter or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity: A stepped-wedge, cluster-randomised trial
- PMID: 36074760
- PMCID: PMC9455881
- DOI: 10.1371/journal.pmed.1004087
Tighter or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity: A stepped-wedge, cluster-randomised trial
Abstract
Background: Treatment for gestational diabetes mellitus (GDM) aims to reduce maternal hyperglycaemia. The TARGET Trial assessed whether tighter compared with less tight glycaemic control reduced maternal and perinatal morbidity.
Methods and findings: In this stepped-wedge, cluster-randomised trial, identification number ACTRN12615000282583, 10 hospitals in New Zealand were randomised to 1 of 5 implementation dates. The trial was registered before the first participant was enrolled. All hospitals initially used less tight targets (fasting plasma glucose (FPG) <5.5 mmol/L (<99 mg/dL), 1-hour <8.0 mmol/L (<144 mg/dL), 2 hour postprandial <7.0 mmol/L (<126 mg/dL)) and every 4 months, 2 hospitals moved to use tighter targets (FPG ≤5.0 mmol/L (≤90 mg/dL), 1-hour ≤7.4 mmol/L (≤133 mg/dL), 2 hour postprandial ≤6.7 mmol/L) (≤121 mg/dL). Women with GDM, blinded to the targets in use, were eligible. The primary outcome was large for gestational age. Secondary outcomes assessed maternal and infant health. Analyses were by intention to treat. Between May 2015 and November 2017, data were collected from 1,100 women with GDM (1,108 infants); 598 women (602 infants) used the tighter targets and 502 women (506 infants) used the less tight targets. The rate of large for gestational age was similar between the treatment target groups (88/599, 14.7% versus 76/502, 15.1%; adjusted relative risk [adjRR] 0.96, 95% confidence interval [CI] 0.66 to 1.40, P = 0.839). The composite serious health outcome for the infant of perinatal death, birth trauma, or shoulder dystocia was apparently reduced in the tighter group when adjusted for gestational age at diagnosis of GDM, BMI, ethnicity, and history of GDM compared with the less tight group (8/599, 1.3% versus 13/505, 2.6%, adjRR 0.23, 95% CI 0.06 to 0.88, P = 0.032). No differences were seen for the other infant secondary outcomes apart from a shorter stay in intensive care (P = 0.041). Secondary outcomes for the woman showed an apparent increase for the composite serious health outcome that included major haemorrhage, coagulopathy, embolism, and obstetric complications in the tighter group (35/595, 5.9% versus 15/501, 3.0%, adjRR 2.29, 95% CI 1.14 to 4.59, P = 0.020). There were no differences between the target groups in the risk for pre-eclampsia, induction of labour, or cesarean birth, but more women using tighter targets required pharmacological treatment (404/595, 67.9% versus 293/501, 58.5%, adjRR 1.20, 95% CI 1.00 to 1.44, P = 0.047). The main study limitation is that the treatment targets used may vary to those in use in some countries.
Conclusions: Tighter glycaemic targets in women with GDM compared to less tight targets did not reduce the risk of a large for gestational age infant, but did reduce serious infant morbidity, although serious maternal morbidity was increased. These findings can be used to aid decisions on the glycaemic targets women with GDM should use.
Trial registration: The Australian New Zealand Clinical Trials Registry (ANZCTR). ACTRN12615000282583.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Do glycaemic treatment targets affect the perinatal mental health status of women with gestational diabetes? - Data from the TARGET Trial.BMC Pregnancy Childbirth. 2023 Dec 16;23(1):869. doi: 10.1186/s12884-023-06190-4. BMC Pregnancy Childbirth. 2023. PMID: 38104076 Free PMC article. Clinical Trial.
-
Different intensities of glycaemic control for women with gestational diabetes mellitus.Cochrane Database Syst Rev. 2023 Oct 10;10(10):CD011624. doi: 10.1002/14651858.CD011624.pub3. Cochrane Database Syst Rev. 2023. PMID: 37815094 Review.
-
Tight or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity? (TARGET): study protocol for a stepped wedge randomised trial.BMC Pregnancy Childbirth. 2018 Oct 29;18(1):425. doi: 10.1186/s12884-018-2060-2. BMC Pregnancy Childbirth. 2018. PMID: 30373539 Free PMC article. Clinical Trial.
-
Different intensities of glycaemic control for women with gestational diabetes mellitus.Cochrane Database Syst Rev. 2016 Apr 7;4(4):CD011624. doi: 10.1002/14651858.CD011624.pub2. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2023 Oct 10;10:CD011624. doi: 10.1002/14651858.CD011624.pub3. PMID: 27055233 Free PMC article. Updated. Review.
-
Lower versus higher diagnostic criteria for the detection of gestational diabetes for reducing maternal and perinatal morbidity: study protocol for the GEMS randomised trial.BMC Pregnancy Childbirth. 2020 Sep 18;20(1):547. doi: 10.1186/s12884-020-03252-9. BMC Pregnancy Childbirth. 2020. PMID: 32948138 Free PMC article.
Cited by
-
Neonatal outcomes according to different glucose threshold values in gestational diabetes: a register-based study.BMC Pregnancy Childbirth. 2024 Apr 12;24(1):271. doi: 10.1186/s12884-024-06473-4. BMC Pregnancy Childbirth. 2024. PMID: 38609891 Free PMC article.
-
Transition of the genital mollicutes from the second to the third trimester of pregnancy and its association with adverse pregnancy outcomes in GDM women: a prospective, single-center cohort study from China.BMC Pregnancy Childbirth. 2024 Apr 3;24(1):233. doi: 10.1186/s12884-024-06418-x. BMC Pregnancy Childbirth. 2024. PMID: 38570745 Free PMC article.
-
Intensive glycaemic targets in overweight and obese individuals with gestational diabetes mellitus: clinical trial protocol for the iGDM study.BMJ Open. 2024 Feb 29;14(2):e082126. doi: 10.1136/bmjopen-2023-082126. BMJ Open. 2024. PMID: 38423770 Free PMC article.
-
Adverse perinatal outcomes in gestational diabetes mellitus with and without SARS-CoV-2 infection during pregnancy: results from two nationwide registries in Germany.BMJ Open Diabetes Res Care. 2024 Jan 25;12(1):e003724. doi: 10.1136/bmjdrc-2023-003724. BMJ Open Diabetes Res Care. 2024. PMID: 38272538 Free PMC article.
-
Do glycaemic treatment targets affect the perinatal mental health status of women with gestational diabetes? - Data from the TARGET Trial.BMC Pregnancy Childbirth. 2023 Dec 16;23(1):869. doi: 10.1186/s12884-023-06190-4. BMC Pregnancy Childbirth. 2023. PMID: 38104076 Free PMC article. Clinical Trial.
References
-
- Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus. Part 1: diagnosis and classification of diabetes mellitus: World Health Organization Report. Diabet Med. 1998;15:539–553. - PubMed
-
- HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al.. Hyperglycaemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002. - PubMed
-
- Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. The Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477–2486. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical